Testing ways to improve sleep and cut sitting time in type 2 diabetes
Tests sleep therapy and sitting-reduction coaching in adults with type 2 diabetes.
Key facts
- Who runs it
- University of Leicester
- Where
- Leicester, United KingdomSee the site
- Trial code
- Registry title
- A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus
- Status
- Recruiting
- People taking part
- 44 people, planned
- Started
- 2 Sept 2024
- Planned end
- Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- CBTi
- Control - usual care
- Sedentary behaviour reduction
- Record updated
- 27 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 75 with type 2 diabetes and sleep problems (insomnia symptoms). It tests coaching to improve sleep and reduce sitting time.
- Age
- 18 to 75 years
- Sex
- Men and women can join.
- Disease stage
- Type 2 diabetes diagnosed for longer than 3 months, with insomnia symptoms (score of 5 or more on the insomnia part of the SDS-CL-25). HbA1c of 10% (86 mmol/mol) or less (86 mmol/mol).
- Earlier treatment
- Treatment must have been stable for at least 3 months. People cannot be taking opioids.
- Biomarker or test result
- Sleep efficiency of 85% or less measured by an accelerometer. A score below 5 on the STOP BANG scale (low risk of undiagnosed sleep apnoea); diagnosed and treated sleep apnoea is acceptable.
Main reasons for not taking part
- Narcolepsy or a diagnosed parasomnia
- Type 1 diabetes or gestational diabetes
- Heart or blood vessel event in the last 6 months
- Shift work, epilepsy or seizures, or terminal illness
- Currently pregnant or planning pregnancy during the study
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Diagnosed with Diabetes Mellitus type 2 for longer than 3 months
- Participant is willing and able to give informed consent to take part in the study
- Sleep disorder symptom checklist 25 (SDS-CL-25) of ≥5 on insomnia criteria
- Not at high risk of undiagnosed Obstructive Sleep Apnoea (OSA), scoring ≥5 on STOP BANG scale (snoring, tired, observed, pressure, body mass index, age, neck size, gender) diagnosed treated OSA is acceptable
- Glycated haemoglobin (HbA1c) of 10% or less (86 mmol/mol) or less
- Male or Females
- ≥ 18 ≤ 75 years of age
- Able to walk without the use of an assistive device or requiring assistance from another person
- Not undertaking more than 75 minutes a week of strenuous exercise or sport
- Not taking opioids
- Be treatment stable for at least 3 months
- Accelerometer measurement of SE ≤ 85%
- An understanding that CBTi may exacerbate sleep deprivation in the short term which may impact on certain aspects of daily life
Who cannot take part
- Currently on opioids
- Individuals with type 1 diabetes or gestational diabetes
- Diagnosed with borderline personality disorder, psychosis, adult attention deficit hyperactivity disorder (ADHD) or schizophrenia (self-reported)
- Individuals living with epilepsy or seizures
- Terminal illness
- Individuals living with narcolepsy or diagnosed parasomnia
- Recent cardiovascular event (within the last 6 months)
- Shift workers
- Female participant planning to become pregnant with the timeframe of the study or is currently pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United Kingdom
- Diabetes Research Centre University Hospitals LeicesterLeicester, United KingdomContact: Alix HA Covenant, MScTaking people
About the trial
What the trial wants to find out
The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems. The main questions it aims to answer are: • question 1, can objectively measured sleep and sedentary behaviour be improved in the participants and • question 2, what effect will this have on a number of physical and physiological markers. Participants in the intervention group will be asked to keep sleep diaries and attend regular meetings with a qualified coach who will use a specific talking therapy to try to improve sleep and with use behaviour change techniques to help them be less sedentary. Researchers will compare the control group to the intervention group to see if effects differ between groups.
The 2 groups in the trial
- CBTi and Sedentary Behaviour supportTreatment being tested
Participants will be counselled in how to improve their sleep and decrease sedentary behaviour using CBTi and behaviour change techniques.
Treatment: CBTi and Sedentary behaviour reduction
- Control - usual careExisting treatment, for comparison
Participants will be given a leaflet containing brief information on good sleep hygiene practice and the benefits of decreasing sedentary behaviour.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- An Efficacy Study Exploring the Optimisation of Sleep and the Reduction of Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus
- Plain-language title
- Testing ways to improve sleep and cut sitting time in type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06471634, who can take part
- Record updated
- 27 March 2025